Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Houston, Texas 25 trials found
New Search
Filter
Trial Phase
Study Type
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
N/AOBSERVATIONAL Gilbert, Arizona +4 more
RECRUITING
Long-Term Follow-Up of Recipient of Gene Transfer Research
N/AOBSERVATIONAL Houston, Texas
RECRUITING
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
NAINTERVENTIONAL Houston, Texas
RECRUITING
Childhood Cancer Survivor Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
NAINTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
PHASE1, PHASE2INTERVENTIONAL Santa Rosa, California +4 more
RECRUITING
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Norwalk, Connecticut +4 more
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
PHASE1INTERVENTIONAL Houston, Texas
RECRUITING
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
NAINTERVENTIONAL Houston, Texas +1 more
RECRUITING
Converting HR+ Breast Cancer Into an Individualized Vaccine
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
NAINTERVENTIONAL Houston, Texas
RECRUITING
Trial of DFP-14927 in Advanced Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +1 more
RECRUITING
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
PHASE1INTERVENTIONAL Houston, Texas
RECRUITING
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
N/AOBSERVATIONAL Pittsburgh, Pennsylvania +4 more
RECRUITING
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
PHASE2INTERVENTIONAL Houston, Texas
RECRUITING
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
N/AOBSERVATIONAL Houston, Texas +2 more
RECRUITING
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
N/AOBSERVATIONAL Conroe, Texas +3 more
RECRUITING
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +3 more
RECRUITING
Filter Trials
Trial Phase
Study Type